- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02458820
Prompt Diagnosis and Treatment of Subclinical Seizures After Cardiac Arrest
Non-convulsive seizures (NCS) following cardiac arrest are common and are associated with worse neurologic outcomes and increased mortality. More prolonged seizures (status epilepticus) are associated with worse outcomes. Earlier diagnosis and treatment of seizures may lead to earlier termination of seizures and decreased seizure burden.
This study will evaluate whether bedside intensive care unit (ICU) provider interpretation of a type of EEG called DSA EEG can be used by non-neurologists to diagnosis seizures more rapidly than continuous EEG's routinely read by neurologists.
Study Overview
Detailed Description
Acute symptomatic electroencephalographic (EEG) seizures are common in children who experience a cardiac arrest, and are associated with worse short term survival. In larger studies of critically ill children with heterogeneous acute encephalopathy etiologies, EEG seizures occur in 10-40% of monitored patients, and there is increasing evidence that high seizure burdens are associated with worse outcomes. Furthermore, status epilepticus treatment delays are associated with reduced medication efficacy for status epilepticus termination. The majority of EEG seizures in critically ill children have no clinical correlate and therefore detection requires EEG monitoring. Many institutions do not have access to continuous EEG monitoring services. Additionally, even when EEG "monitoring" is performed, data review is generally intermittent, leading to delays between seizure onset and detection.The purpose of the study is to determine the efficacy of real-time DSA pattern interpretation for the detection of seizures by bedside ICU practitioners.The primary objective of this study is to determine the whether the real-time DSA patterns interpreted by bedside ICU practitioners can decrease the time to accurate NCS detection following pediatric cardiac arrest. All subjects who receive chest compressions and have return of spontaneous circulation and are cared for the CHOP Pediatric Intensive Care Unit (PICU) will be screened. If patients meet inclusion criteria they will be approached for consent. Written informed consent will be obtained from parents/guardians. Assent will not be obtained as these children are intubated and comatose after arrest.Patients will be randomly assigned to receive standard of care, continuous EEG monitoring, versus continuous EEG monitoring plus real-time ICU provider DSA interpretation. This will go on for the duration of clinically indicated EEG monitoring.
For patients enrolled in the standard continuous EEG arm of the study, EEG will be recorded and interpreted as per standard of care. If a seizure is noted by the neurology service, the standard seizure treatment protocol will be used by the clinical team.Patients monitored with standard EEG and DSA will undergo at least hourly interpretation of DSA by the ICU bedside care provider. If the bedside care provider is concerned that there is a seizure on DSA they will contact the EEG tech on call for confirmation. If a seizure is confirmed by neurology, the standard seizure treatment protocol will be used by the clinical team.Following completion of EEG intervention arms, the patients will be followed and discharge survival and discharge Pediatric Cerebral Performance Category (PCPC) will be documented.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Children's Hospital of Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects age > 48 hours
- Return of Spontaneous Circulation (ROSC) for > 20 minutes after a cardiac arrest
- Treated in the PICU
- Clinical team ordering continuous EEG monitoring
Exclusion Criteria:
- Age < 48 hours old and < 38 weeks gestational age
- No available computers with DSA software
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Usual Care
Patients will be recorded and interpreted as per standard of care.
If a seizure is noted by the neurology service, the standard seizure treatment protocol will be used by the clinical team.
|
|
|
Experimental: DSA EEG + Usual Care
Patients will undergo at least hourly interpretation of DSA by the ICU bedside care provider.
If the bedside care provider is concerned that there is a seizure on DSA they will contact the EEG tech on call for confirmation.
If a seizure is confirmed by neurology, the standard seizure treatment protocol will be used by the clinical team.
|
Color density spectral array (DSA) is a quantitative electroencephalogram (EEG) technique that uses Fourier transformation to present EEG power (amplitude2/Hz, by color) and frequency (y-axis) over time (x-axis).
It is commercially available and used routinely by neurophysiologists for EEG interpretation.
Up to several hours of EEG can be displayed as a single image.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average time from EEG seizure onset to seizure recognition
Time Frame: 3 days
|
EEG monitoring and DSA interpretation by ICU practitioners will continue for the duration of clinically indicated EEG monitoring which will be no more than 3 days.
The average time from seizure onset to seizure recognition between the EEG group and the EEG + DSA group will be compared.
|
3 days
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexis Topjian, MD, MSCE, Children's Hospital of Philadelphia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-011635
- 5K23NS075363 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Seizures
-
Eisai Inc.CompletedPartial Onset Seizures | Primary Generalized Tonic-Clonic Seizures | Secondarily Generalized SeizuresUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedPsilocybin | Psychogenic Nonepileptic SeizuresFrance
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedGeneralized Tonic Clonic SeizuresKorea, Republic of, United States, Austria, Serbia, India, Spain, Poland, Malaysia, China, Bulgaria, Denmark, Greece, Hungary, United Kingdom, Belarus, France, Montenegro, Philippines, Romania, Russian Federation, Slovakia, Ukraine, Lebano... and more
-
Lundbeck LLCCompletedAdult Refractory Complex Partial SeizuresUnited States
-
University Hospital, BordeauxCompletedPsychogenic Nonepileptic Seizures (PNESs)France
-
UCB Biopharma SRLRecruitingStereotypical Prolonged SeizuresUnited States, Bulgaria, China, Germany, Hungary, Italy, Japan, Poland, Spain, United Kingdom, Czechia, France, Australia
-
Eisai Co., Ltd.RecruitingPartial-Onset Seizures | Primary Generalized Tonic-clonic SeizuresJapan
-
ValexfarmCompletedEpilepsy | Complex Partial Seizures | Simple Partial Seizures | Partial Seizures With Secondary GeneralizationRussian Federation
-
UCB Biopharma SRLEnrolling by invitationStereotypical Prolonged SeizuresUnited States, Bulgaria, China, Germany, Hungary, Italy, Japan, Poland, Spain, United Kingdom, Czechia, Australia
-
Central Hospital, Nancy, FranceCompletedPsychogenic Non-epileptic SeizuresFrance
Clinical Trials on DSA EEG
-
Wuhan Union Hospital, ChinaNot yet recruiting
-
University Hospital, BrestUnknown
-
National Taiwan University HospitalCompleted
-
Wuhan General Hospital of Guangzhou Military CommandCompleted
-
Kyungpook National University HospitalCompletedDiagnostic ImagingKorea, Republic of
-
First Affiliated Hospital of Shantou University...RecruitingHeart Diseases | Cardiovascular Diseases | Atrial Fibrillation | Arrhythmias, CardiacChina
-
Sakarya UniversityThe Scientific and Technological Research Council of TurkeyCompletedPain | Satisfaction, Patient | Sciatic Nerve | Injection Site | NursesTurkey
-
Sakarya UniversityNot yet recruitingPostoperative Agitation | Emergence Delirium, Anesthesia
-
First People's Hospital of HangzhouCompletedCoronary Artery Disease | Coronary Microvascular DiseaseChina
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandRecruitingIntracerebral Hemorrhage | Nontraumatic Intracerebral HemorrhageSwitzerland